Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.
about
Can we prevent antimicrobial resistance by using antimicrobials better?Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infectionsUniversal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trialEffect of meteorological factors and geographic location on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in the US.The impact of Contact Isolation on the quality of inpatient hospital care.Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic reviewHospital discharge instructions: comprehension and compliance among older adultsMRSA nasal carriage patterns and the subsequent risk of conversion between patterns, infection, and death.Does universal active MRSA surveillance influence anti-MRSA antibiotic use? A retrospective analysis of the treatment of patients admitted with suspicion of infection at Veterans Affairs Medical Centers between 2005 and 2010Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York HospitalAssociation between contact precautions and delirium at a tertiary care centerValidity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease?Association between methicillin-resistant Staphylococcus aureus colonization and infection may not differ by age group.Healthcare-associated infection and hospital readmission.The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance.Utility of prior screening for methicillin-resistant Staphylococcus aureus in predicting resistance of S. aureus infectionsPredictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia.Surveillance and management of multidrug-resistant microorganisms.Prevention of nosocomial infections and surveillance of emerging resistances in NICU.A three-year survey of the antimicrobial resistance of microorganisms at a Chinese hospital.Usefulness of previous methicillin-resistant Staphylococcus aureus screening results in guiding empirical therapy for S aureus bacteremia.Laboratory evaluation of the BD MAX MRSA assay.Selective bactericidal activity of nanopatterned superhydrophobic cicada Psaltoda claripennis wing surfaces.Long-Term Impact of Universal Contact Precautions on Rates of Multidrug-Resistant Organisms in ICUs: A Comparative Effectiveness Study.
P2860
Q26829707-9F146421-B6A5-4920-B6CE-072FD8E8A085Q30678060-356FC094-78D1-416E-99A6-FF0F02AB190DQ33632050-A9DA9990-3964-4AF9-91D9-A5884C57B9B4Q33739246-F510A55C-91F5-4F31-8BEE-8F9A494F60D4Q33979742-AEB3C6FD-2531-4BE3-8C17-9AF81E9DC1F6Q34503284-A127E253-996D-4C0D-95A9-5840FEAA16A4Q34546329-2BC23181-D7BC-4B71-8A70-DA603BEF2AC8Q34551656-ED19F0F3-2316-4A83-8763-76C52E9B5BFDQ34974836-C94C7129-95BA-40E3-B28C-252234CF2B4EQ36501398-60D5D178-67E2-4F1E-BDDB-B552AE4EDC60Q36529085-DFDBE71A-C4EB-4B55-A0A5-AB298DC8EBE3Q36873127-43CA0931-E682-46B1-9337-FEF35FEEEDCFQ36915923-C3649B7E-8DF1-41AC-9322-04857A0941CEQ36915965-FD269071-117A-4374-8495-37B0681EF2CFQ36968334-E876ABEA-3D50-4685-A609-4071819C7C27Q37229727-C28A6168-B9FE-4958-8840-B855BA194EFCQ37544795-8724431A-8161-40BD-86D9-B0A21119C55FQ37912231-E5862C27-9C6D-49E3-A148-DE58AED20AC9Q37937631-95761A26-2B95-4973-9577-FF562D9FFDE0Q38718214-B6BED3E3-2DF4-4651-9209-6080A8E49E8BQ41004977-19FF7F55-5CFF-4BB2-A1DD-57CE510A96C2Q42735583-317C0ADF-BB80-4370-B1F9-4F33DD9F558AQ46687903-709EB028-9FDA-45F4-8028-CCDD6EEB0623Q54251586-CE28F8B5-0330-4FD6-8BC1-9FF9606E258A
P2860
Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeted surveillance of methi ...... de empiric antibiotic therapy.
@ast
Targeted surveillance of methi ...... de empiric antibiotic therapy.
@en
Targeted surveillance of methi ...... de empiric antibiotic therapy.
@nl
type
label
Targeted surveillance of methi ...... de empiric antibiotic therapy.
@ast
Targeted surveillance of methi ...... de empiric antibiotic therapy.
@en
Targeted surveillance of methi ...... de empiric antibiotic therapy.
@nl
prefLabel
Targeted surveillance of methi ...... de empiric antibiotic therapy.
@ast
Targeted surveillance of methi ...... de empiric antibiotic therapy.
@en
Targeted surveillance of methi ...... de empiric antibiotic therapy.
@nl
P2093
P2860
P356
P1476
Targeted surveillance of methi ...... de empiric antibiotic therapy.
@en
P2093
Anita C Moore
Anthony D Harris
Eli N Perencevich
Harold C Standiford
Jennifer K Johnson
Joan N Hebden
Jon P Furuno
Laurie J Conway
Marin L Schweizer
Mary-Claire Roghmann
P2860
P304
P356
10.1128/AAC.01590-09
P407
P577
2010-05-17T00:00:00Z